Blockade of Beta-Catenin/ALDH1 Axis Toward Effective Suppression of High Metastatic Osteosarcoma: Preclinical Study of a Novel Wnt/Beta-Catenin Pathway Inhibitor Tegavivint

被引：0
|
作者：
Nomura, Motonari [1 ,2 ,3 ]
机构：
[1] Osaka Univ, Grad Sch Univ, Dept Pediat Surg, Osaka, Japan
[2] Natl Inst Biomed Innovat Hlth & Nutr, Osaka, Japan
[3] Texas Childrens Hosp, Baylor Coll of Med, Houston, TX 77030 USA
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES7-3-2
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [31] Impaired Wnt/beta-catenin and protein patched homolog 1 signaling in extraocular sebaceous carcinoma: A clinical and histopathological study
    Cheng, An-Yu
    Lan, Jui
    Lee, Chih-Hung
    JOURNAL OF DERMATOLOGY, 2022, 49 (06): : 600 - 606
  • [32] The Wnt/beta-catenin pathway as a novel therapeutic target to selectively inhibit pathological liver progenitor cells during chronic liver disease
    Pasic, S.
    Pohl, S. O.
    Olynyk, J. K.
    Tosh, D.
    Adams, L. A.
    Dharmarajan, A.
    Tirnitz-Parker, J. E. E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 31 - 32
  • [33] TC1(C8orf4) enhances the Wnt/beta-catenin pathway by relieving antagonistic activity of Chibby
    Lee, Inchul
    Song, Kyuyoung
    Jung, Yusun
    Bang, Seunghyun
    Kim, Jungtae
    Kim, Youngmi
    Kim, Eunsoon
    Park, Juhee
    CANCER RESEARCH, 2006, 66 (08)
  • [34] Drug repurposing of niclosamide to regulate Wnt/beta-catenin signaling pathway through upregulating SFRP1 in colorectal cancer.
    Wu, Mia Mingxia
    Tong, Christy Wing Sum
    Yan, Vivi Wei
    To, Kin-wah
    CANCER RESEARCH, 2021, 81 (13)
  • [35] Targeting glutaminase 1 attenuates sternness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
    Li, Binghua
    Cao, Yajuan
    Meng, Gang
    Qian, Liyuan
    Xu, Tiancheng
    Yan, Chen
    Luo, Ouyang
    Wang, Shaohe
    Wei, Jiwu
    Ding, Yitao
    Yu, Decai
    EBIOMEDICINE, 2019, 39 : 239 - 254
  • [36] Lymphoid Enhancer Binding Factor 1 (LEF1) as a Biomarker for Wnt/Beta-Catenin Pathway Activation in the Biological Progression of Phyllodes Tumors
    Chen, Po-Han
    Bossuyt, Veerle
    Reisenbichler, Emily
    MODERN PATHOLOGY, 2019, 32
  • [37] Lymphoid Enhancer Binding Factor 1 (LEF1) as a Biomarker for Wnt/Beta-Catenin Pathway Activation in the Biological Progression of Phyllodes Tumors
    Chen, Po-Han
    Bossuyt, Veerle
    Reisenbichler, Emily
    LABORATORY INVESTIGATION, 2019, 99
  • [38] A novel beta 2-AR/YB-1/beta-catenin axis mediates chronic stress-associated metastasis in hepatocellular carcinoma
    Liu, Jinxia
    Qu, Lishuai
    Wan, Chunhua
    Xiao, Mingbing
    Ni, Wenkai
    Jiang, Feng
    Fan, Yihui
    Lu, Cuihua
    Ni, Runzhou
    ONCOGENESIS, 2020, 9 (09)
  • [39] Proteasome Inhibitor, Bortezomib Induces Mesenchymal Stem Cells toward Osteoblast Differentiation through Wnt-independent Activation of beta-catenin/TCF Signaling
    Qiang, Y.
    Hu, B.
    Chen, Y.
    Zhong, Y.
    Barlogie, B.
    Shaughnessy, J.
    BONE, 2010, 47 : S283 - S284
  • [40] Proteasome Inhibitor, Bortezomib Induces Mesenchymal Stem Cells toward Osteoblast Differentiation through Wnt-Independent Activation of Beta-catenin/TCF Signaling
    Qiang, Ya-Wei
    Hu, Bo
    Chen, Yu
    Zhong, Ying
    Shi, Bingyin
    Barlogic, Bart
    Shaughnessy, John D., Jr.
    BLOOD, 2008, 112 (11) : 240 - 240
12345